Kliniken der Stadt Köln gGmbH - Krankenhaus Merheim - Lungenklinik

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy	Hemic and Lymphatic Diseases, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, blood coagulation disease, cardiovascular disorder, disseminated intravascular coagulation, hematologic disorder, hemorrhagic disease, thrombophilia, vascular disorder, vascular hemostatic disease	Recruiting	Phase 1	2026-09-23		NCT06854640
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)	Advanced Non-small Cell Lung Cancer, HER2 Mutation	Recruiting	Phase 3	2026-09-23		NCT06452277

Clinical trials